Protective effects of eplerenone on podocyte injury in adriamycin nephropathy rats

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 3, 2011, Pages 329-334

  Fang, Zhan ^a,b   Zhang, Chun ^a   He, Fangfang ^a   Chen, Shan ^a   Sun, Xifeng ^a   Zhu, Zhonghua ^a   Liu, Jianshe ^a   Meng, Xianfang ^c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Yantai Mountain Hospital   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Adriamycin; Desmin; Eplerenone; Nephropathy; Podocyte; TGF 1

Indexed keywords

CYTOKINE; DOXORUBICIN; DRUG DERIVATIVE; EPLERENONE; MINERALOCORTICOID ANTAGONIST; PROTECTIVE AGENT; SPIRONOLACTONE;

ANIMAL; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DOWN REGULATION; DRUG EFFECT; GLOMERULUS; KIDNEY DISEASE; MALE; METABOLISM; PATHOLOGY; PODOCYTE; PROTEINURIA; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CYTOKINES; DOWN-REGULATION; DOXORUBICIN; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MINERALOCORTICOID RECEPTOR ANTAGONISTS; PODOCYTES; PROTECTIVE AGENTS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; SPIRONOLACTONE;

EID: 80455123689     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0376-5     Document Type: Article

References (12)

1. Nagase M, Fujita T. Aldosterone and glomerular podocyte injury. Clin Exp Nephrol, 2008,12(4):233-242
2. Kiyomoto H, Rafiq K, Mostofa M, et al. Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury. J Pharmacol Sci, 2008,108(4):399-405
3. Guo C, Martinez-Vasquez D, Mendez GP, et al. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus. Endocrinology, 2006,147(11):5363-5373 (Pubitemid 44790591)
4. Nielsen FT, Jensen BL, Marcussen N, et al. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin A nephrotoxicity in conscious rats. Nephrol Dial Transplant, 2008,23(9):2777-2783
5. Lam EY, Funder JW, Nikolic-Paterson DJ, et al. Mineralocorticoid receptor blockade but not steroid withdrawal reverses renal fibrosis in deoxycorticosterone/salt rats. Endocrinology, 2006,147(7):3623-3629. (Pubitemid 43901155)
6. De las Heras N, Ruiz-Ortega M, Miana M, et al. Interac factor in vascular and renal damage in spontaneously hypertensive rats. J Hypertens, 2007,25(3):629-638
7. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol, 2007,106(2):26-31
8. Yoshida S, Nagase M, Shibata S, et al. Podocyte injury induced by albumin overload in vivo and in vitro: involvement of TGF-beta and p38 MAPK. Nephron Exp Nephrol, 2008,108(3):e57-68 (Pubitemid 351592585)
9. Iglesias-de la Cruz MC, Ziyadeh FN, Isono M, et al. Effects of high glucose and TGF-beta1 on the expression of collagen II and vascular endothelial growth factor in mouse podocytes. Kidney Int, 2002,62(3):901-913 (Pubitemid 35316719)
10. Fujisawa G, Okada K, Muto S, et al. Spironolactone prevents early renal injury in streptozotocininduced diabetic rats. Kidney Int, 2004,66(4):1493-1502 (Pubitemid 39298382)
11. Juknevicius I, Segal Y, Kren S, et al. Effect of aldosterone on renal transforming growth factor-beta. Am J Physiol Renal Physiol, 2004,286(6):F1059-1062 (Pubitemid 38656360)
12. Kerjaschkj D, Neale TJ. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis). J Am Soc Nephrol, 1996,7(12): 2518-252